Morrison Kendall

Introduction

Morrison Kendall, an accomplished inventor based in Santa Monica, CA, has made significant contributions to the field of biotechnology. With a focus on antibody compositions, he aims to advance treatments for cancer and immunological disorders. His innovative work has garnered attention for its potential impact on patient care.

Latest Patents

Morrison Kendall holds a patent for "Antibody compositions comprising Fc mutations and site-specific conjugation properties for use in treating cancer, immunological disorders, and methods thereof." This patent details antibodies that specifically bind to target antigens such as Her2, EGFR, Trop2, and CDH3, featuring a unique triple mutation at L234A, L235A, and L328C. The technology showcases how these antibodies can exhibit modified effector functions through Fc silencing and enable site-specific conjugation at L328C to create antibody-drug-conjugates (ADCs). This advancement paves the way for innovative cancer, immunological, and neurological disorder treatments.

Career Highlights

Morrison Kendall is associated with Tae Life Sciences, LLC, where his research and development efforts focus on leveraging antibody technology to create meaningful therapeutic solutions. His expertise and innovative mindset have established him as a key player in the development of advanced medical treatments.

Collaborations

In his endeavors, Kendall collaborates closely with talented colleagues, including Sohye Kang. Together, their combined expertise in biotechnology enables them to push the boundaries of what is possible in medical science, particularly in the fields of oncology and immunology.

Conclusion

Morrison Kendall's work exemplifies the crucial intersection of innovation and healthcare. Through his patent and ongoing research, he continues to contribute significantly to the development of advanced treatments that hold promise for improving the lives of patients battling cancer and other immunological disorders.